DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2220369/bls-jobs-up-big-353k-3-7-unemployment?cid=CS-ZC-FT-ahead_of_wall_street-2220369 Feb 02, 2024 - 353K new jobs created for January are nearly double the 180K or so analysts were looking for. 0

https://www.zacks.com/stock/news/2220349/abbvie-abbv-reports-q4-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2220349 Feb 02, 2024 - The headline numbers for AbbVie (ABBV) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. 0

https://www.fool.com/investing/2024/01/28/2-high-yield-healthcare-stocks-to-buy-with-both-ha/?source=iedfolrf0000001 Jan 28, 2024 - All three of these stocks offer attractive dividend yields, but one looks risky. 0

https://www.zacks.com/stock/news/2214367/gilead-gild-down-as-nsclc-study-fails-to-meet-primary-goal?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2214367 Jan 23, 2024 - Gilead Sciences' (GILD) phase III study evaluating Trodelvy (sacituzumab govitecan) in previously treated metastatic NSCLC fails to meet its primary endpoint. Shares decline on the same. 0

https://www.zacks.com/commentary/2210770/q4-earnings-season-scorecard-and-analyst-reports-for-apple-abbvie-toyota?cid=CS-ZC-FT-research_daily-2210770 Jan 16, 2024 - Today's Research Daily features a real-time update on the Q4 earnings season and new research reports on Apple (AAPL), AbbVie (ABBV), Toyota Motor (TM) and others. 0

https://www.zacks.com/stock/news/2208771/want-better-returns-don-t-ignore-these-2-medical-stocks-set-to-beat-earnings?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2208771 Jan 11, 2024 - Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP. 0

https://www.zacks.com/stock/news/2207004/abbvie-abbv-now-trades-above-golden-cross-time-to-buy?cid=CS-ZC-FT-tale_of_the_tape|golden_crossover-2207004 Jan 08, 2024 - Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average? 0

https://www.zacks.com/stock/news/2206449/will-abbvie-abbv-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2206449 Jan 05, 2024 - AbbVie (ABBV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. 0

https://www.zacks.com/stock/news/2206363/pharma-stock-roundup-lly-s-new-digital-pharmacy-nvo-abbv-s-fresh-r-d-deals?cid=CS-ZC-FT-analyst_blog|stock_roundup-2206363 Jan 05, 2024 - Eli Lilly (LLY) launches a new direct-to-consumer website to provide easy access to its medicines. Novo Nordisk (NVO) announces two research collaborations to develop novel treatments for cardiometabolic diseases. 0

https://www.zacks.com/stock/news/2205271/abbvie-abbv-rises-as-market-takes-a-dip-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2205271 Jan 03, 2024 - AbbVie (ABBV) closed the most recent trading day at $160.46, moving +0.4% from the previous trading session. 0